Products

What will AGI do for Brasofensine maleate?

This classification denotes the brasofensine form of an antiparkinsonian agent with the molecular formula C16H20Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1YP2S94RVH, chemically known as 3-beta-(3,4-dichlorophenyl)-1-alpha-h, 5-alpha-h-tropane-2-alpha-carboxaldehyde (e)-(o-methyloxime). but more generally known as brasofensine, which bears US NIH Compound Identifier 9554198. Brasofensine most often comes in base, maleate, and sulfate forms. European Medicines Agency schedules Brasofensine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05881MIG. The term BRASOFENSINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 11, No. 3 1997, List 38). BRASOFENSINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule brasofensine maleate under HS 29333999 and SITC 51574. As of Q4 2014, BRASOFENSINE MALEATE remains US FDA's Preferred Term for this commodity. Brasofensine maleate bears US NLM identifiers UMLS ID C2698558 and NCI Concept Code C76392. SMILES: CN1[C@H]2CC[C@@H]1[C@@H]([C@H](C2)C3CCC(C(C3)CL)CL)/C=N/OC.C(=C\C(=O)O)\C(=O)O.